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 Abstract 
  Background:  Aphasia affects one third of acute stroke patients. There is a considerable sponta-
neous recovery in aphasia, but impaired communication ability remains a great problem. Com-
munication difficulties are an impediment to rehabilitation. Early treatment of the language 
deficits leading to increased communication ability would improve rehabilitation. The aim of 
this study is to elucidate the efficacy of very early speech and language therapy (SLT) in acute 
stroke patients with aphasia.   Methods:   A prospective, open, randomized, controlled trial was 
carried out with blinded endpoint evaluation of SLT, starting within 2 days of stroke onset and 
lasting for 21 days. 123 consecutive patients with acute, first-ever ischemic stroke and aphasia 
were randomized. The SLT treatment was Language Enrichment Therapy, and the aphasia tests 
used were the Norsk grunntest for afasi (NGA) and the Amsterdam-Nijmegen everyday lan-
guage test (ANELT), both performed by speech pathologists, blinded for randomization.   Re-
sults:   The primary outcome, as measured by ANELT at day 21, was 1.3 in the actively treated 
patient group and 1.2 among controls. NGA led to similar results in both groups. Patients with a 
higher level of education (  1  12 years) improved more on ANELT by day 21 than those with   ! 12 
years of education (3.4 vs. 1.0, respectively). In 34 patients in the treatment group and 19 in the 
control group improvement was  6 1 on ANELT (p  !  0.05). There was no difference in the degree 
of aphasia at baseline except for fluency, which was higher in the group responding to treat-
ment.   Conclusions:   Very early intensive SLT with the Language Enrichment Therapy program 
over 21 days had no effect on the degree of aphasia in unselected acute aphasic stroke patients. 
In aphasic patients with more fluency, SLT resulted in a significant improvement as compared to 
controls. A higher educational level of   1  12 years was beneficial.    Copyright © 2011 S. Karger AG, Basel 
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 Introduction 
  Aphasia affects one third of acute stroke patients   [1–3]  . In a majority of them, there is a 
considerable spontaneous recovery in aphasia during the first months after stroke onset, but 
half of the patients still have aphasia at 18 months, although in a milder form   [1]  . Aphasia 
secondary to intracerebral hemorrhage usually has a better recovery rate than aphasia due 
to cerebral infarcts of similar size   [4]  . The four major components of the classic aphasic syn-
dromes are: comprehension, repetition, naming, and fluency. Comprehension usually shows 
earlier and complete recovery and is essential for basic communication. Nevertheless, per-
sistent, even if less pronounced, impaired communication ability remains a great problem 
for the individual aphasic patient.
    Speech and language therapy (SLT) in patients with aphasia has been recommended 
  [5]  . The most recent Cochrane systematic review suggests that SLT might be of some ben-
efit in patients with aphasia following stroke   [6]  . This review included a study by Wertz et 
al.  [7]  which showed a small effect. However, almost all patients in these studies had chron-
ic aphasia, i.e. with a duration of  1 3 months after stroke onset. Furthermore, intensive SLT 
over a short period of time proved to provide a better outcome than less intensive regimens 
over a longer period   [6, 8]  . New therapies like constraint-induced therapy, suppressing 
non-verbal communication in favor of verbal communication, and transcranial magnetic 
stimulation to cortical language areas have shown positive outcomes for a specific treat-
ment target item, but the improvement could not be generalized to other language do-
mains   [9, 10]  .
    Communication difficulties, especially comprehension deficit, are an impediment to 
rehabilitation. Very early mobilization is suggested to be one reason for the positive effect of 
stroke unit care. Early treatment of the language deficits leading to an increased communi-
cation ability would improve the whole rehabilitation process   [11]  .
    The aim of this study is to evaluate the efficacy of very early SLT in acute aphasic stroke 
patients in a randomized controlled trial.
  Materials  and  Methods 
  Patients and Design 
  This is a prospective, randomized, controlled trial with blinded endpoint evaluation 
of very early SLT for 21 days compared to a control group. Patients with acute, first-ever 
ischemic stroke and any degree of aphasia according to the Norsk grunntest for afasi 
(NGA)  [12]  and the possibility to start treatment within 2 days of stroke onset were eligible 
for inclusion. Consecutive, unselected acute stroke patients in our community-based 
Stroke Unit were screened for inclusion. To avoid imbalance in stroke severity between the 
two study groups, the patients were stratified according to the National Institute of Health 
Stroke Scale (NIHSS)   [13]   (  table 1  ). Exclusion criteria were rapid regression, dementia, 
drug abuse, and severe illness. Randomization was performed centrally by an independent 
statistician using consecutive sealed envelopes. Both groups were given information on 
aphasia, prognosis, and support. The patients were tested with aphasia tests, NIHSS, and 
Activities of Daily Living at baseline, after 3 weeks, and at 6 months. Educational level was 
assessed as more or less than 12 years at school, which is equivalent to a high-school de-
gree. More details of the design of the study have been described earlier   [14]  . The Region-
al Ethics Committee approved the study, and patients or relatives gave their written in-
formed consent.68
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Table 1. B  aseline characteristics
Training
(n = 62)
Control
(n = 61)
Age, years (range) 76 (38–94) 79 (39–94)
Male gender, n (%)  33 (58) 23 (41)
Living alone, n (%) 28 (46) 29 (48)
Education >12 years, n (%) 21 (42) 20 (37)
Delay to inclusion, days  3 (2–4) 3 (2–4)
Stratification group, n
NIHSS <10 34 33
NIHSS 11–19 13 13
NIHSS >20 15 15
NIHSS points 9 (4–19) 8 (5–19)
ADL index points 25 (5–85) 45 (5–85)
TOAST stroke types, n
Large vessel 9 14
Cardiac embolic 26 26
Unknown 27 21
OCSP stroke types, n
TACI 7 10
PACI 55 51
ANELT 1 (0–1.4) 1 (0–1.4)
Coeff 10.5 (4–33) 13 (4–33)
Fluency 31 (1.5–47) 33 (1.5–49)
Comprehension 10 (4–22) 9 (4–20)
Repetition 1 (0–11) 0 (0–7)
Naming 0 (0–5) 0 (0–7)
Atrial fibrillation, n (%) 26 (41) 25 (41)
Hypertension, n (%)  35 (56) 33 (54)
Congestive heart failure, n (%) 8 (13) 11 (18)
History of myocardial infarction, n (%) 14 (23) 3 (5)
Angina pectoris, n (%) 10 (16) 9 (15)
Hyperlipidemia, n (%) 37 (69) 27 (50)
Current smoker, n (%)  15 (25) 8 (13)
Peripherial artery disease, n (%) 2 (3) 1 (2)
Diabetes mellitus, n (%) 9 (15) 7 (11)
Carotic stenosis (>50%), n (%) 5 (15) 7 (18)
Systolic blood pressure, mm Hg 143 (130–160) 150 (140–165)
Diastolic blood pressure, mm Hg 80 (74–86) 80 (70–85)
Heart rate, beats/min 76 (64–85) 76 (64–80)
Blood glucose, mmol/l 6.6 (5.8–7.3) 6.4 (5.8–7.3)
S-creatinine, mol/l 86 (74–100) 88 (77–107)
Total cholesterol, mmol/l 4.9 (4.1–5.8) 4.8 (4.1–5.3)
LDL-cholesterol, mmol/l 3.1 (2.4–3.9) 2.8 (2.3–3.4)
C-reactive protein, mg/l 6 (4–18) 9 (4–15)
D  ata are presented as median values and quartiles, if not otherwise stated. ADL = Activities of Daily 
Living, Barthel Index; TOAST = Trial of Org 10172 in Acute Stroke Treatment [18]; OCSP = Oxfordshire 
Community Stroke Project [19]; TACI = total anterior circulation infarct; PACI = partial anterior circula-
tion infarct; LDL = low density lipoprotein.69
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  Aphasia  Tests 
  Two tests for aphasia were used. A short adjusted version of NGA was employed, which 
is a valid and reliable standard test to assess the degree and the type of aphasia by measuring 
fluency, comprehension, repetition, and naming   [12]  . The sum of the scores of comprehen-
sion, repetition, and naming yields the aphasia coefficient (Coeff), which is equivalent to the 
degree. Coeff has a range of 0–59, where a value of 59 is normal. Percentile values give each 
patient’s raw score for the variables naming, repetition, and comprehension in relation to the 
score of the whole group of these aphasic subjects. The relation between the percentile value 
of three parameters and fluency, measured as words per minute, estimated from spontane-
ous speech gives the type of aphasia. Fluency was tape recorded. The second test for aphasia 
used was the Amsterdam-Nijmegen everyday language test (ANELT), a functional test, 
though verbal   [15]  . ANELT is a valid, reliable test for aphasia. The testing procedure with 
ANELT was also tape recorded. ANELT measures the degree of aphasia on a 1–5 point scale, 
where 5 equals normal. A score of 0 was given when the patient, due to severe aphasia, was 
incapable of taking instructions and/or producing an answer. The NGA and ANELT tests 
have been described in detail elsewhere   [16]  . All tests for aphasia were performed by three 
speech pathologists who had been trained together and blinded as to the randomization. The 
tapes were assessed by yet another speech pathologist with great experience with these tests 
and unaware of randomization and any of the previous test results.
  T h e r a p y  
  The SLT treatment used was Language Enrichment Therapy (LET)   [17]  . The LET pro-
gram focuses on exercise in comprehension and to some extent in naming in a hierarchic 
edified program. This is the most commonly used SLT in the clinical setting in Scandinavia 
(with the exception of computerized programs). The LET program describes exactly how to 
do the exercises and is therefore easily reproducible. Nothing in the LET program resembles 
the ANELT test. LET was carried out by five co-trained speech pathologists. The therapy 
consisted of 45-min long sessions every weekday over 21 days. Treatment per protocol in the 
active treatment arm was defined as at least 600 min of therapy (maximum 720 min), while 
in the control group no SLT was given during the same period. All patients were encouraged 
to communicate with relatives and staff.
  Following the 21-day intervention period, all patients could receive SLT at the discretion 
of the responsible physician. However, the number of subsequent SLT treatment sessions per-
formed was reported and counted.
  Statistical  Methods 
  As previously described, the primary outcome was the difference in the degree of apha-
sia between the two study groups measured by the ANELT score at day 21. The secondary 
measure of outcome was the difference in the recovery rate in Coeff between the two groups 
at day 21 (Diff Coeff)   [14]  . A predetermined improvement on the ANELT scale of   6  1 at day 
21 was considered clinically relevant, whereas 0.5 was considered too small to be clinically 
relevant   [14]  . The power was set at 90% and the two-sided level of significance at 5%. With 
52 patients in each group, a difference of at least 0.75 in ANELT, considered clinically worth-
while, was secured. The primary analysis was conducted in accordance with intention-to-
treat.
    Data are presented as median values and quartiles, if not otherwise stated. Contingency 
tables were evaluated by the     2   test. Statistical comparisons between groups were made by 
the Wilcoxon signed rank test. For multivariate regression analyses, multivariate analysis of 
variance was used. All analyses were carried out with the JMP, version 7.0 (SAS Institute Inc., 
Cary, N.C., USA).70
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  R e s u l t s  
 General  Results 
  We randomized 123 aphasic patients of which 114 (93%) completed the study and could 
be tested on day 21 (  fig. 1  ). Follow-up at 6 months could be performed in 99 patients (80%). 
There were no significant differences in baseline characteristics between the study groups, 
except for a history of myocardial infarction, which was more frequent in the intervention 
group (  table 1  ). At the follow-up at 6 months, 5 patients in the intervention group and 6 in 
the control group had died. Five patients in each group had recurrent stroke. All recurrent 
strokes occurred beyond the 3 weeks of intervention.
    Primary and Secondary Outcomes 
  The primary outcome in the whole group as measured by ANELT by day 21 was 1.3 
among the SLT-treated patients and 1.2 among the controls (  table 2  ). The Diff Coeff was 8.5 
in the SLT group and 9 in the control group. Also, per protocol analyses of ANELT by day 21 
and for Diff Coeff revealed no statistical difference between the two study groups (  table 2 ).
    Patients with a higher level of education (  1  12 years) improved more in ANELT by day 
21 than those with   !  12 years of education [3.4 (1.0–4.8) vs. 1.0 (1.0–2.7); p   !   0.01]. Diff Coeff 
improved more in patients with   1  12 years of education than in those with   !  12 years of edu-
cation [13 (8–26) vs. 8 (1–16); p   !   0.01].
    Higher values of ANELT, Coeff, fluency, and comprehension at baseline had a positive 
effect on ANELT by day 21 (p   !   0.01), while worse neurological performance as indicated by 
higher NIHSS values at baseline and longer delay to inclusion had a negative effect on ANELT 
by day 21 (p   !   0.01) and on Diff Coeff (p   !   0.05).
    A multivariate analysis including baseline ANELT, Coeff, fluency, and NIHSS at base-
line, as well as age, gender, delay to inclusion, intervention group, and level of education, 
confirmed that initial ANELT and length of education had an independent, significant im-
pact on the primary outcome (i.e. ANELT by day 21). For secondary outcome (i.e. Diff Coeff), 
the impact of the initial NIHSS and educational level were significant.
Dead n = 6
Severely ill
n = 6
6 months
Refused 
testing n = 3
Severely ill
n = 2
Tested
n = 49
Controls
n = 61
Receiving
SLT
n = 62 
Acute
Per protocol
n = 51 3 weeks
Tested
n = 56
Severely ill
n = 2
Dead
n = 1
Refused 
testing n = 1
Missing data
n = 1
Dead n = 4
Severely ill
n = 3
Tested
n = 50
Per protocol
n = 54
Tested
n = 59
Randomized
n = 123
  Fig. 1.   Flow chart for random-
ized patients. 71
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    The types of aphasia are shown in   figure 2  . There were no differences in aphasia types 
between the two groups. Only 9 patients had a fluent type of aphasia at baseline, and there 
were no differences in fluent/non-fluent types of aphasia between the two groups. Best out-
come according to ANELT at 3 weeks was seen in transcortical sensory aphasia, followed by 
isolation, conduction, and Wernicke type of aphasia. Patients with global aphasia had the 
poorest outcome.
    Follow-Up at 6 Months 
 At 6 months, ANELT and Coeff were similar in the two study groups ( table 2 ). The num-
ber of non-study SLT sessions after day 21 was 15 (4–38) in the treatment group and 10 (5–20) 
in the control group (p = 0.3).
  ANELT at 6 months of follow-up was 4.5 (1.9–5.0) among those with an education of  1 12 
years and 1.5 (1.0–3.6) among those with less education (p  !  0.01). For Coeff at 6 months, the 
corresponding results were 57 (39–59) and 39 (17–55) (p   !   0.01).
    Subgroup Analyses, Responders versus Non-Responders 
  These analyses were performed post hoc. Results in the 53 aphasic stroke patients who 
improved  6 1 on ANELT (i.e. an improvement which was predetermined to be clinically rel-
evant; responders) are presented in   table 3  . The 34 responders in the SLT treatment group 
were compared to those 25 patients who improved   !  1 on ANELT (non-responders). NIHSS 
Table 2. P  rimary and secondary outcomes
Training group Control group p value
Primary outcomes
ANELT by day 21, intention-to-treat, n 59 55
Median  1.3 (1–4.1) 1.2 (0–3.6) 0.37
ANELT by day 21, per protocol, n 54 49
Median  1.5 (1–4.1) 1.0 (0–3.6) 0.16
Secondary outcomes
Difference in coefficient at baseline and day 21, intention-to-treat, n 58 56
Median 8.5 (1–17) 9 (3.3–16.8) 0.86
Difference in coefficient at baseline and day 21, per protocol, n 53 48
Median  9 (1.5–17.5) 8.5 (2.3–16) 0.62
Follow-up at 6 months
ANELT, n 50 49
Median  1.8 (1–4.6) 3 (1–4.6) 0.49
Coefficient, n 50 49
Median  40 (25–57) 49 (17–58) 0.62
D  ata are presented as median values and quartiles. 
Table 3.   Effects of SLT at day 21 according to ANELT
SLT group
(n = 59)
Control group
(n = 55)
p
Patients with a difference in ANELT
≥1 from baseline to day 21 34 responders 19 <0.01
<1 from baseline to day 21 25 non-responders 3672
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at baseline was lower in the responder group than in the non-responder group [5 (2–12) vs. 
11 (7–20); p   !   0.01]. Aphasia tests showed no difference at baseline except for fluency, which 
was 37 (30–64) words/min in the responder group and 8 (1.5–30) words/min in the non-re-
sponder group (p   !   0.001). There were no differences in types of aphasia. The responders 
improved in all three parts of the NGA (comprehension, naming, and repetition), as com-
pared to the non-responders (all p   !   0.01). At 6 months of follow-up, a difference in ANELT 
remained between responders and non-responders [2.7 (1.2–4.9) vs. 1.1 (0.8–1.6);
p   !   0.01]. Among those with a fluency of   1  30 words/min (n = 51), more patients improved 
  1  1 on ANELT in the intervention group than among controls (18 vs. 6 patients; p   !   0.05).
  Discussion 
  This randomized controlled trial revealed that very early SLT with the LET program 
does not affect the primary and secondary outcomes of the degree of aphasia in unselected 
patients with aphasia after first-ever ischemic stroke. The study had an adequate statistical 
power, and the tests used for primary and secondary outcomes are robust and measure the 
total degree of aphasia. Only ischemic stroke patients were included, since patients with in-
tracerebral hemorrhage are often more affected in the acute stage and have a higher mortal-
ity rate. Compared to our previous findings in aphasic patients   [1, 18]  , the subjects in the 
present study were more affected regarding the severity of the stroke and the degree of apha-
sia. As there is a rapid early spontaneous improvement, this can be due to the much shorter 
time from symptom onset in the present study   [1, 18]  . The participants in the current study 
compare well to the average patient with aphasia very early after an acute ischemic stroke. 
Accordingly, we regard the results as externally valid.
    The potential for improvement is greatest for those patients with the most severe degree 
of aphasia. The possibility to reach the best results, however, is greatest for patients with mild 
aphasia. The most important factors for improvement are the initial degree of aphasia and 
the degree of neurological deficit at baseline   [1]  .
    Comprehension is the base for communication and a prerequisite to assimilate rehabili-
tation. Thus, we used the well-defined and easily reproducible LET program, which first of 
all examines comprehension   [17]  . For patients with good comprehension, the LET program 
can concentrate more on naming exercises.
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    In patients with more fluency, SLT showed significant improvement at day 21, resulting 
in a milder degree of aphasia; these favorable effects remained at 6 months. The aphasic pa-
tients with more fluency and less paresis (probably reflecting a posterior lesion) seemed to 
be those who benefited most from SLT. However, these findings were performed post hoc 
and must be interpreted with caution. Further studies need to verify these observations.
    In this study, the educational level had an independent impact on the recovery of apha-
sia both in short- and long-term outcome. There was no difference in stroke severity or de-
gree of aphasia at baseline between those with an education of more or less than 12 years. 
Others have found no correlation between educational level and functional outcome for 
aphasic patients   [19]  . A possible explanation of our findings is that patients with a higher 
educational level may have a greater potential for learning during the recovery period and 
that their premorbid personality may reflect a greater learning capacity.
  Conclusions 
 Very early intensive SLT with the LET program does not improve outcome in unselected 
acute ischemic stroke patients with aphasia. An educational level of more than 12 years was 
beneficial. However, a post hoc analysis showed that a group of patients with more fluency 
seemed to improve significantly, primarily due to comprehension exercise, with the possible 
benefit effect lasting for 6 months after stroke onset. Thus, very early intensive SLT cannot 
generally be recommended in acute aphasic patients. The findings of improvement in pa-
tients with more fluency warrant further investigation and evaluation of the efficacy of al-
ternative treatments.
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